🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if a combined treatment approac...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine
Start Date
2025-04-01
Trial ID
NCT07193654
The goal of this clinical trial is to test whether adding preventive intrat...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine
Start Date
2026-01-04
Trial ID
NCT07511725
Glioblastoma is the primary brain tumour with the worst prognosis: median s...
Status
Completed
Location
Hospital Universitario Virgen del Rocío
Start Date
2023-08-18
Trial ID
NCT03529448
Treatments Being Tested
The purpose of this study is to test the the efficacy and safety of Anlotin...
Status
Completed
Location
Zhejiang cancer hospital
Start Date
2019-03-19
Trial ID
NCT04119674
This study was to explore the effectiveness and safety of early TMZ chemoth...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2015-11-08
Trial ID
NCT05600491
Treatments Being Tested
Glioblastoma (GBM) is the most common primary malignant brain tumor in adul...
Status
Not Yet Recruiting
Location
Tianjin Medical University General Hospital
Start Date
2026-09-01
Trial ID
NCT07758062
Treatments Being Tested
O6-méthylguanine méthyltransférase (MGMT) is the main repair gene after DNA...
Status
Terminated
Location
Institut de Cacerologie de l'ouest - site Paul Papin
Start Date
2013-01
Trial ID
NCT01700569
Single arm, monocentric trial to assess the safety and the progression-free...
Status
Recruiting
Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Start Date
2021-03-25
Trial ID
NCT04523688
Treatments Being Tested
This is a prospective, single-arm study. The study population consists of a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-03
Trial ID
NCT07707973
Treatments Being Tested